| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3400545 | Enfermedades Infecciosas y Microbiología Clínica | 2016 | 6 Pages |
Abstract
The lack of differences between groups suggests that highly active antiretroviral treatment regimens including nevirapine administered during pregnancy do not involve a higher risk of liver disease compared to other treatment combinations.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
Pablo Iveli, Antoni Noguera-Julian, Pere Soler-PalacÃn, Andrea MartÃn-Nalda, Núria Rovira-Girabal, Clà udia Fortuny-Guasch, Concepció Figueras-Nadal,